Why Attend
CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.
The fourth annual CAR-T congress USA is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy.
Join discussions with Dr Christina Coughlin and Dr Leonard Lichtenfeld to determine how we avoid cheaper and more potent biologics hindering the progress of CAR-T, how we effectively edit T cells at scale, and how the industry is pushing for patient access to accelerate your CAR-T pipelines.
Discover first-hand the novel research being done by one of the leading ‘biotechs to watch’ Tmunity, as we explore the potential of CAR-T switches to control and manage CAR-T therapy effectively. Join Fate Therapeutics, TCR2 and Cellectis to determine how novel CAR-T constructs and gene editing technology are paving the way for the next generation CAR-Ts.
With two tracks for preclinical discovery and clinical development, refine your methods from optimizing T cell phenotypes and longevity to providing quality control for robust manufacturing. With sessions ran by Gilead and Legend Biotech on strengthening the business strategy for CAR-T and global regulation sessions ran by the EMA, this is your chance to be informed when commercialising your CAR-T therapy.
Be part of the movement that engineers a strategy to reprogram the cancer treatments we know today.
Take a look at our highlights video from 2018:
CAR-T 2018 IMAGE GALLERY
TESTIMONIALS
WHO WILL BE THERE
Network with industry experts from:
- Big pharma and biotech
- Cell Therapy Academics and clinicians
- Process standardisation - technology/services
- Logistics companies - cell storage/transport
- Service providers - CRO’s, Consultants, Government
Past attendees include:
The Agenda
Take a look at our agenda preview for the hot topics we'll be covering. Please fill in your details so we know who to send this too.
Check out the highlights from 2018:
Download Agenda
The Speakers

Kim Nguyen, PhD
Kim is a part of the Cell Therapy team at Precision Biosciences focused on the process development, analytics, and manufacturing of allogeneic CAR-T cell products. Before joining Precision Biosciences, she served as Principal Scientist and Senior Manager for Strategic Initiatives at Terumo BCT. Kim received her AB from Princeton University and her Ph.D. from Columbia University, both in Chemistry. She enjoys cooking Vietnamese food, reading, and adventures with her adorable Jack Russell terrier, Grover, aka Mr. Shambles.

Robert Hofmeister

Dan Shoemaker

Ali Mohamed

Paul Lammers

Professor David Miklos

Therese Solstad Saunders

Professor Saar Gill

Professor Sattva Neelapu

Peter Emtage
Dr. Emtage currently serves as Chief Scientific Officer at Cell Design Labs, Inc. (CDL). Prior to joining CDL, he was Vice President of Synthetic Immunology at Intrexon Corporation and was Vice President of Immune Mediated Therapy in the Oncology Innovative Medicines group at Medimmune. At Medimmune, Dr. Emtage designed and implemented a comprehensive immune therapy cancer strategy. He has over sixteen years of biologics development experience in the fields of oncology, autoimmunity, infectious diseases, and inflammation. Dr. Emtage holds a B.S. and M.S. in Molecular Biology and Genetics from the University of Guelph and received his Ph.D. in Molecular Virology, Immunology and Inflammation at McMaster University. At the beginning of his career, he also was a post-doctoral fellow at the National Institutes of Health and held roles at Aventis Pasteur and Harvard Medical School.

Dr. John McHutchinson

Dr. Christina Coughlin

Hans-Peter Gerber

Dr. Alexandre Juillerat

Dr. Leonard Lichtenfeld

Dr. Francesco Galimi

Dr. Avery Posey

Dr. Saul Priceman

Fred Koller, Ph.D.

Welf Ludwig

Dr. Qiong Wang

Dr. Matthew Spear

Dr. Kristen Hege

Rob Margolin

Dominic Clarke

Ryan Crisman, PhD

Dr Angeliki Grammenos
Angeliki has held positions in academia and biopharma, with a special focus in cell therapy.
Angeliki is a physicist by training and has a PhD in biophysics specialized in cell biology. She left her teaching position at the University of Liège in 2012, to join the international office of Doctors Without Borders where she assisted the Ethical review board as well as the Quality Assurance department of the movement.
In 2015, she joined Bone Therapeutics S.A, a biopharmaceutical company dedicated to the development of cell therapy products based on autologous and allogeneic adult stem cell technology to treat unmet medical needs in the field of bone disease where she led the RA Department.
In 2018, Angeliki joined Celyad, a biopharmaceutical company specialized in autologous and allogeneic cell therapy. Celyad’s core business lies in immune-oncology and the development of NK-receptor based CAR T therapies.

Dr. Leon Song

Dawn Driscoll

Madhusudan Peshwa

Stefano Baila
Stefano Baila received his PhD in 2007 based upon translational research and development of gene therapies for hemophilia at the Children’s Hospital of Philadelphia. Since that time he has been actively involved in the process development and manufacturing of advanced therapeutic medicinal products through business development and strategic marketing roles at Areta International, a CDMO, and by leading field implementation and commercialization activities for the cell processing unit of Terumo BCT. Stefano also worked as Industrialization Manager at Celyad where he led process development and automation efforts for CAR-T therapeutics. Now he serves as Director of Operation and Business Development for Anemocyte.
Headline Partner
Roche Custom Biotech
Website: https://custombiotech.roche.com/
You are driving a paradigm shift. Scientific and technological advances emerging from creative companies across the globe are transforming the way we look at disease and breaking down boundaries for treatment. Now more than ever, business success hinges on working with advisors and suppliers who understand your needs and allow you to focus on what matters most.
What if all of those needs were met by a single partner — a market leader with decades of experience in biotechnology and in vitro diagnostics?
Introducing Roche CustomBiotech.
Leveraging the unique know-how of Roche Diagnostics and Roche Pharmaceuticals, we work with you to deliver high quality raw materials, instrumentation, products and services for your biopharmaceutical, cell therapy, or in vitro diagnostics business, customized to your unique quality and regulatory needs.
Platinum Partners
Anemocyte
Website: http://www.anemocyte.com
Anemocyte is a Biotech Manufacturing Organization (BMO); a biotech company active in the field of Cell and Gene Therapies (CGTs) that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations.
Our business:
- Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells, Vesicles)
- Plasmids for Viral Vector Manufacturing.
- Project Exellula: to address up to commercial scale needs for CGTs Including Viral Vectors modified cells.
- Big Data Analysis of CGTs
Our experience:
- More than 15 years of GMP manufacturing of CGTs and biological drugs;
- More than 60 years of Contract Manufacturing within our Group (Nine Trees Group)
GenScript Biotech
Website: https://www.genscript.com/
GenScript Biotech is the world leader in biotechnology reagent service industry. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for custom peptide synthesis, protein expression and engineering, custom antibody development and engineering, animal model development, in vitro/in vivo pharmacology as well as a variety of catalogue products, industrial enzymes and microbial reagents.
Miltenyi Biotec
Website: http://www.miltenyibiotec.com
At Miltenyi Biotec, we are committed to enabling the delivery of new cell and gene therapy (CGT) treatment options to patients with unmet medical needs. We develop tailored cell processing protocols for our GMP-compliant cell processing platform, the CliniMACS Prodigy®, to enable fully closed and automated manufacturing of complex CGT products. In addition, we offer contract development and GMP manufacturing of CGT products as well as design, development, and production of tailored GMP lentiviral vectors
Gold partners
TrakCel
Website: http://www.trakcel.com
A critical factor facing the industry is choosing technologies and partners that can deliver scale. The challenges inherent in translating early clinical trials to a reproducible and robust process suitable for scalable commercial production are very significant. Each personalized drug product ultimately depends on a sustainable and consistent supply chain with lots of moving parts. Configured to your exact demands, using an industry-standard framework, TrakCel’s comprehensive supply chain platform ensures every resource is managed, monitored, recorded and is ultimately performed exactly as required. From sample collection through logistics, manufacturing and final transplantation, with comprehensive chain of custody, chain of identity and traceability, TrakCel’s proven technology integrates and orchestrates every aspect of your autologous and allogeneic supply chains in a scalable, compliant and validated technology platform.
Werum IT Solutions
Website: https://www.werum.com
Werum IT Solutions is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Our out-of-the-box PAS-X software product is run by the majority of the world’s top 30 pharmaceutical and biotech companies but also by many mid-sized manufacturers.
Werum’s manufacturing IT solutions help pharma manufacturers to increase efficiency, improve productivity, and meet regulatory requirements. The range of projects includes global MES programs with multi-site rollouts all over the world as well as single-site solutions in individual countries.
Founded in 1969, Werum is headquartered in Lüneburg, Germany, and has many locations in Europe, America, and Asia.
HemaCare
Website: https://www.hemacare.com/
HemaCare is a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery and cellular therapy process development. The company’s network of FDA-registered, GMP/GTP-compliant collection centers ensure fresh donor material is available to customers and for use within HemaCare’s isolation laboratory. Human biological material including peripheral blood, bone marrow, and cord blood is isolated into various primary cells types for fresh and frozen distribution. For 40 years, HemaCare has developed an extensive registry of repeat donors and provides human-derived primary blood cells and tissues for biomedical and drug discovery research and cell therapy clinical trials, and supports commercialization with apheresis collections, directly enabling customers to advance both autologous and allogeneic cellular therapies.
Gates Biomanufacturing Facility
Website: http://gatesbiomanufacturing.com/
The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus is a 14,000 square ft. GMP compliant manufacturing facility that provides cell-based therapies and protein biologics for use in preclinical investigations and Phase I and Phase II human clinical trials. The GBF was established in 2015 though partnership with the Gates Center for Regenerative Medicine, University of Colorado Health, Children’s Hospital of Colorado, University of Colorado-School of Medicine, and the Gates Frontiers Fund.
Our Mission is to accelerate the translation of scientific discoveries into human clinical trials as safely, efficiently, and cost effectively as possible according to high quality standards. We serve academic researchers, clinicians, early stage biotechnology companies and established pharmaceutical companies throughout the US.
In connection with our manufacturing, we provide the following services:
- Cell therapy and Protein product process development, consultation, and support
- Cell therapy and Protein product manufacturing, characterization, storage, and distribution
- Regulatory consultation and support
- Quality control
- Quality assurance managed through an electronic Quality Management System (QMS) with a dedicated staff of 16 people.
nanoString
Website: https://www.nanostring.com/
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System, which has been employed in basic and translational research and cited in 1,000+ peer review publications, has also now been applied to diagnostic use with the nCounter Dx Analysis System. The company is committed to offering tools that enable scientists and clinicians to translate today’s leading genomic research into clinically actionable tests that improve patient care. Gene expression panels for immune- oncology, autoimmunity, CAR-T and other applications are ready off the shelf tools offered to the Nanostring customers.
Janssen Oncology
Website: https://www.janssen.com/oncology
Our mission is to transform individual lives and fundamentally change the way diseases are managed, interpreted, and prevented. We believe that challenging something is the best way to change it. So every day, in more than 150 countries, we bring cutting-edge science and the most creative minds in the industry together to think differently about diseases. We aim not only to innovate but also to empower people with the tools they need to make informed decisions and achieve the best possible results for their health.
Event Partners
ChemoMetec
Website: http://chemometec.com
ChemoMetec is a Danish founded company, which specializes in the development, manufacturing and sales of high-quality automated Cell Counters, Advanced Cell Analyzers and Image Cytometers to help streamline research, process development, and manufacturing processes for maximum efficiency. Our instruments are based on a patented, unique technology platform that ensures high quality analysis of results and consistency between samples. The instruments are known for their robustness and high precision, as well as advanced analysis capabilities with a user friendly interface.
Our technology is rapidly becoming the gold standard for cell count and viability in the field of CAR-T and T-cell therapy. The reason for this is that our cell counters deliver the highest level of precision amongst all counting methods, as well as being 21CFR part 11 ready. Part of the secret to this precision is the Via-Cassette TM which eliminates user error due to sample/reagent mixing and pipetting. In addition, every cassette is individually volume calibrated to ensure accurate calculation of cell concentration. Also, every instrument is calibrated to a master instrument to ensure that you get the most precise count possible. This eliminates inter-instrument variation between your CAR-T research team, manufacturing, and QC monitoring of the final product.
NanoEnTek
Website: http://www.nanoentek.com
NanoEnTek aims to develop innovative and easy to use products for life science research and help life science researchers consume their time and passion for discovery, instead of repetitive and tedious work. NanoEnTek always keeps our initial mission in mind and help researchers contribute for the better world.
The first successful products was Countess, the world's first personal cell counter which was a shift in paradigm of cell counters. Following this success, it developed the series of other cell counters; ADAM-MC automated cell counter, ADAM-SCC somatic cell counter, and Arthur novel fluorescence cell counter. The second success came from ADAM-rWBC, the world's first benchtop residual white blood cell counter with FDA 510(k) cleared. It has been selected as the QC standard equipment of the American Red Cross (ARC) and installed in more than 200 blood banks globally.
Through the strong performance (high-accuracy, speed and usability) and customer’s satisfaction, the new product (Adam-MC2/CellT) for CAR-T manufacturing process QC is presented in this congress. It can even fulfill all your needs as well from the research level to the large-scale multi-site manufacturing.
PeproTech
Website: http://www.peprotech.com
Established in 1988 by a group of scientists, PeproTech is a privately owned biotechnology company focusing on the development and manufacture of high quality cytokine products for the life-science and cell therapy markets. Over the past 30 years the company has grown into a global enterprise with state-of-the-art manufacturing facilities in the US, and offices around the world.
With over 2,000 products PeproTech has developed and refined innovative protocols to ensure quality, reliability and consistency.
Our mission is to provide the highest quality products to support the needs of today’s scientists and researchers.
Please contact: 800-436-9910 or [email protected]
StemExpress
Website: https://www.stemexpress.com/
StemExpress provides leading biomedical researchers around the world human hematological samples at life-changing speed. Our nationwide procurement network and state-of-the-art collection centers ensure StemExpress can reliably obtain the highest quality and most varied source material, including Leukopaks, peripheral and maternal blood, and bone marrow. Isolated cell lines are purified less than 24 hours from procurement, guaranteeing the purity, viability, and quality you need.
CellGenix
Website: http://www.cellgenix.com
CellGenix is a leading global supplier of high quality reagents and tools in the expanding market of cell and gene therapy and regenerative medicine.
As the first company to obtain a GMP manufacturing authorization for cell processing in Europe, CellGenix has more than 20 years of expertise in the development and GMP manufacturing of cell therapy products. Our products are used worldwide in clinical trials by academia and industry partners.
To ensure a seamless transition from research to commercialization we offer our customers a comprehensive product portfolio together with expert regulatory and technical support. Included in our product portfolio are cytokines, serum-free media and closed cell culture systems. Our products combine a maximum of quality and safety with excellent performance due to the state-of-the-art production, stringent in-house quality control and comprehensive documentation. All these factors help to simplify qualification and validation for your market authorization.
CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA.
BioSpherix
Website: http://www.BioSpherix.com
BioSpherix will be exhibiting the Xvivo System, the only cytocentric barrier isolator optimized for cells. Economical alternative to cleanrooms for cGMP compliant production of cells for clinical use. Stop by BioSpherix booth to learn more about the only total quality platform for cells!
Total quality recognizes that for best cell potency, cells need full-time optimization of all critical cell process parameters. Total quality recognizes that all typical negative side effects of machines on cells (particles, heat, vibration, etc.) must be neutralized and those machines must be protected from dust, aerosols, and corrosion. Total quality recognizes that each entire cell production line (all manual and automated steps) must be protected from microbial contamination. Total quality recognizes that all personnel must be fully protected from cells harboring virus, vectors, prion, and other pathogens. Total quality recognizes that scaling up and out must be efficient and cost efficient.
Media Partners
BioInformant
Website: https://www.bioinformant.com
As the first and only market research firm to specialize in the stem cell industry, BioInformant research has been cited by the Wall Street Journal, Xconomy, and Vogue Magazine. Today, BioInformant.com is the world's largest publisher of cell therapy industry news, serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs.
Cell Therapy News
Website: http://www.celltherapynews.com
Connexon Creative’s mission is to accelerate science and facilitate science communication by providing tools that enhance the way scientific and medical professionals keep up with recent findings, science news and exciting advances in specific areas of immunology and cell biology research.
Gene Therapy Net
Website: http://www.genetherapynet.com
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
pharmaphorum
Website: http://pharmaphorum.com
pharmaphorum is a content and communications company offering a unique hybrid of publisher and agency working in pharma and healthcare.
pharmaphorum.com is our own independent flagship publication. It serves over 3 million unique users annually and its news and information is widely recognised as a leading source of thought leadership and strategic content for pharmaceutical professionals all over the world.
Our innovative digital magazine Deep Dive provides cutting edge insight on pharma industry trends to an audience of 100K per issue.
ADC Review
Website: http://www.adcreview.com
ADC Review / Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international publication combining professional social media with an online-only, hybrid open-access, peer reviewed journal.
The Journal is designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, (basic, translational and clinical) research, clinicians/physicians, along with regulatory affairs, government authorities and representatives from payers, and policy makers.
Onco' Zine
Website: http://www.oncozine.com
Onco’Zine, The International Oncology Network – is a Social Media based, journal relies heavily on in-person specialized coverage of scientific meetings and conferences. Correspondents throughout the United States, Canada and Europe supply first-hand reports and interviews with researchers, clinicians, and industry and government figures whose work and actions are changing the practice of oncology and hematology. As a Social Media based peer-to-peer/professional network Onco’Zine also welcomes contributions and discussions from healthcare professionals.
Human Gene Therapy
Website: http://www.liebertpub.com/hgt
Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.
BioProcess International Magazine
Website: http://www.bioprocessintl.com
BioProcess International magazine covers the whole bioprocessing industry: biotherapeutic process and product development and biomanufacturing.
CanBiotech
Website: https://www.canbiotech.com/
CanBiotech is an open innovation and patient engagement platform for the biotech and pharmaceutical industries. Visit CanBiotech to learn more about best practices for collaboration with industry stakeholders and patients. Participate in the discussion, attend upcoming events and training opportunities provided by CanBiotech and our partners in the areas of innovation program development, open bioinnovation, design thinking for health and patient engagement.
FierceBiotech
Website: http://www.fiercebiotech.com
Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.
FierceBiotech and its family of publications provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way.
We track tiny, virtual startups and the biggest of Big Pharma, highlighting the accomplishments and acknowledging the defeats that all of them experience on their way to market with a new therapy or device.
The FierceBiotech team transcends the daily as well, with comprehensive coverage of key medical meetings plus special reports that highlight up-and-comers and shed new light on industry heavyweights.
RegMedNet
Website: http://www.regmednet.com
RegMedNet is a networking site that unites all members of the diverse regenerative medicine community, enabling them to share the latest news, inspiration and insights, and connect and collaborate in order to help this exciting field move forward at an even faster rate. Read expert editorials, watch interviews and access exclusive journal content free.
Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
Venue
Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA 02128
This year's 4th Annual CAR-T Congress will be taking place in Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA 02128
Hyatt Regency Boston Harbor is an intimate and boutique-style Harborside hotel with breathtaking views of the beautiful city skyline. Guests will appreciate the proximity to Logan Airport and the hotel’s complimentary airport shuttle. Boston’s famed cultural and historical sites, recreational options, and neighborhoods are just minutes away and easily accessible through our many public transportation options available including the MBTA Train and Water Taxi.
Unfortunately, there are no rooms available at the Hyatt Regency, please contact the Embassy Suites Hotel near Logan Airport who have rooms available. The Embassy Suites Hotel is a 6-minute taxi from the Hyatt Regency or alternatively, there is a free shuttle bus between the hotels.
Accessibility:
We are committed to making our event accessible to everyone. If you are traveling for the event, Cloud of Goods provides mobility scooter rentals, wheelchair rentals, and other mobility solutions. They will deliver directly to you at the event, your hotel, the airport, or any other place of your choosing. Event attendees will receive a 20% discount when they use the code: RENTGEAR032
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.